Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Definitive Healthcare (DH) Accumulated Expenses (2020 - 2025)

Definitive Healthcare (DH) has disclosed Accumulated Expenses for 6 consecutive years, with $44.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Accumulated Expenses rose 9.48% year-over-year to $44.8 million, compared with a TTM value of $44.8 million through Dec 2025, up 9.48%, and an annual FY2025 reading of $44.8 million, up 9.48% over the prior year.
  • Accumulated Expenses was $44.8 million for Q4 2025 at Definitive Healthcare, up from $41.9 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $51.5 million in Q4 2023 and bottomed at $16.7 million in Q1 2021.
  • Average Accumulated Expenses over 5 years is $31.4 million, with a median of $30.3 million recorded in 2023.
  • The sharpest move saw Accumulated Expenses surged 261.23% in 2021, then dropped 25.0% in 2025.
  • Year by year, Accumulated Expenses stood at $28.0 million in 2021, then fell by 4.04% to $26.9 million in 2022, then surged by 91.88% to $51.5 million in 2023, then fell by 20.63% to $40.9 million in 2024, then grew by 9.48% to $44.8 million in 2025.
  • Business Quant data shows Accumulated Expenses for DH at $44.8 million in Q4 2025, $41.9 million in Q3 2025, and $31.3 million in Q2 2025.